Mark Mansour is a partner at Jones Day. He has practiced U.S. and international food and drug law since 1991. He works with clients in the food, pharmaceutical, medical device, dietary supplement, and cosmetic industries to develop and implement strategies for regulatory approvals, compliance and enforcement actions, and rulemaking and public policy issues. He counsels corporations and organizations on how to negotiate effectively with government agencies in the U.S. and abroad. Mark is recognized as a pioneer in the development of regulatory strategies that address the need to manage approvals not only in the U.S., but in other international markets as well, along with promoting efforts to achieve regulatory harmonization. He has been actively involved with industry and government to achieve solutions to issues such as the regulation of biotechnology and nanotechnology. He is active in domestic and international industry groups involving the key regulated industries. In addition, he has assisted clients in managing numerous FTC consumer protection matters. His FTC experience involves investigations, enforcement actions, negotiations and consent decrees, involving marketing, advertising, and privacy matters, as well as advertising disputes before the NAD. Mark is a leading speaker on regulatory matters, domestically and internationally. He has served as assistant general counsel and director of global regulatory affairs with two of the world's largest FDA regulated companies. He has managed numerous major recalls since 1997, including major events such as melamine, heparin, and peanut butter, among others. He also has taken a lead role in drafting industry comments in response to key rulemaking activities over the past 20 years.